Yangfeng Ding

932 total citations · 1 hit paper
44 papers, 529 citations indexed

About

Yangfeng Ding is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Yangfeng Ding has authored 44 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 24 papers in Dermatology and 8 papers in Molecular Biology. Recurrent topics in Yangfeng Ding's work include Psoriasis: Treatment and Pathogenesis (34 papers), Dermatology and Skin Diseases (23 papers) and Autoimmune Bullous Skin Diseases (7 papers). Yangfeng Ding is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (34 papers), Dermatology and Skin Diseases (23 papers) and Autoimmune Bullous Skin Diseases (7 papers). Yangfeng Ding collaborates with scholars based in China, Australia and Taiwan. Yangfeng Ding's co-authors include Ning Yu, Yuling Shi, Jiajing Lu, Wenjuan Chen, Ying Li, Linsheng Huang, Renyuan Gao, Huanlong Qin, Yefei Zhu and Chen Peng and has published in prestigious journals such as Frontiers in Immunology, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Yangfeng Ding

39 papers receiving 524 citations

Hit Papers

Association between systemic immune inflammation index, s... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES
    2024 54 citations Rui Ma, Lian Cui et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangfeng Ding China 13 311 238 122 78 68 44 529
Aleksandra Batycka-Baran Poland 12 273 0.9× 280 1.2× 148 1.2× 65 0.8× 72 1.1× 40 558
Maya Debbaneh United States 13 399 1.3× 232 1.0× 115 0.9× 82 1.1× 56 0.8× 16 582
R. Salgo Germany 8 241 0.8× 190 0.8× 91 0.7× 44 0.6× 68 1.0× 11 495
Hugo Oliveira Portugal 8 378 1.2× 191 0.8× 101 0.8× 64 0.8× 76 1.1× 27 476
Mette Gyldenløve Denmark 13 230 0.7× 103 0.4× 126 1.0× 90 1.2× 56 0.8× 31 596
Bingni Chen China 7 245 0.8× 83 0.3× 101 0.8× 44 0.6× 88 1.3× 11 417
Bożena Chodynicka Poland 14 361 1.2× 140 0.6× 139 1.1× 59 0.8× 89 1.3× 49 608
Deepak Balak Netherlands 13 241 0.8× 152 0.6× 78 0.6× 23 0.3× 60 0.9× 30 435
S. George United Kingdom 12 269 0.9× 336 1.4× 70 0.6× 34 0.4× 86 1.3× 36 615
Shuaihantian Luo China 8 203 0.7× 105 0.4× 84 0.7× 56 0.7× 104 1.5× 23 374

Countries citing papers authored by Yangfeng Ding

Since Specialization
Citations

This map shows the geographic impact of Yangfeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangfeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangfeng Ding more than expected).

Fields of papers citing papers by Yangfeng Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangfeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangfeng Ding. The network helps show where Yangfeng Ding may publish in the future.

Co-authorship network of co-authors of Yangfeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yangfeng Ding. A scholar is included among the top collaborators of Yangfeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangfeng Ding. Yangfeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Chen, Yue Yin, Yangfeng Ding, et al.. (2025). Association of BMI, BMR, BSA, and body weight with psoriasis severity and treatment response: evidence from a real-world cohort. Journal of Translational Medicine. 23(1). 1129–1129.
2.
3.
4.
5.
Chen, Wenjuan, Jianfeng Zheng, Xin Wang, et al.. (2025). Comorbidity Pattern in Patients with Moderate-to-Severe Plaque Psoriasis: Network Analysis of a Hospitalized Database in China. Clinical Cosmetic and Investigational Dermatology. Volume 18. 491–501.
6.
Ma, Rui, Lian Cui, Jiangluyi Cai, et al.. (2024). Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Frontiers in Immunology. 15. 1323174–1323174. 54 indexed citations breakdown →
7.
Ding, Yangfeng, Wei Li, Xin Guan, et al.. (2023). Treatment outcomes of secukinumab in adult patients with moderate‐to‐severe plaque psoriasis in China: A real‐world multicenter retrospective study. Clinical and Translational Science. 16(10). 1803–1814. 2 indexed citations
8.
Lu, Jiajing, Chunyuan Guo, Peng Chen, et al.. (2023). TLR7-MyD88-DC-CXCL16 axis results neutrophil activation to elicit inflammatory response in pustular psoriasis. Cell Death and Disease. 14(5). 315–315. 15 indexed citations
9.
Ma, Rui, Hui Qin, Wenjuan Chen, et al.. (2023). Sex differences in the association between plasma polyunsaturated fatty acids levels and moderate-to-severe plaque psoriasis severity: a cross-sectional and longitudinal study. Journal of Translational Medicine. 21(1). 834–834. 5 indexed citations
10.
Wang, Aiping, Hang Li, Zhihong Xie, et al.. (2023). Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia. Dermatology and Therapy. 13(7). 1477–1487. 3 indexed citations
11.
Tsai, Tsen‐Fang, Min Zheng, Yangfeng Ding, et al.. (2023). Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial. Dermatology and Therapy. 13(12). 3097–3110. 6 indexed citations
12.
Chen, Wenjuan, Chen Peng, Jianfeng Zheng, et al.. (2022). Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report. Clinical Cosmetic and Investigational Dermatology. Volume 15. 1805–1808. 1 indexed citations
13.
Zhao, Yan, Litao Zhang, Yangfeng Ding, et al.. (2021). Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial. American Journal of Clinical Dermatology. 22(6). 877–889. 43 indexed citations
14.
Yu, Ning, Chen Peng, Wenjuan Chen, et al.. (2021). Circulating Metabolomic Signature in Generalized Pustular Psoriasis Blunts Monocyte Hyperinflammation by Triggering Amino Acid Response. Frontiers in Immunology. 12. 739514–739514. 12 indexed citations
15.
Liu, Na, et al.. (2020). Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report. Acta Dermato Venereologica. 100(15). adv00251–adv00251. 11 indexed citations
16.
Lu, Jiajing, et al.. (2020). Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports. Journal of International Medical Research. 48(3). 1220711643–1220711643. 7 indexed citations
17.
Lu, Xiya, et al.. (2019). Vitiligo in a patient receiving infliximab for chronic plaque psoriasis. Dermatologic Therapy. 32(3). e12917–e12917. 7 indexed citations
18.
Huang, Linsheng, Renyuan Gao, Ning Yu, et al.. (2018). Dysbiosis of gut microbiota was closely associated with psoriasis. Science China Life Sciences. 62(6). 807–815. 67 indexed citations
19.
Zhou, Jing, et al.. (2018). Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis. Lasers in Medical Science. 33(9). 1979–1982. 10 indexed citations
20.
Su, Lina, et al.. (2017). UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study. Lasers in Medical Science. 32(8). 1819–1823. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandra Batycka-Baran Breakdown of academic impact, for papers by Maya Debbaneh Breakdown of academic impact, for papers by R. Salgo Breakdown of academic impact, for papers by Hugo Oliveira Breakdown of academic impact, for papers by Mette Gyldenløve Breakdown of academic impact, for papers by Bingni Chen Breakdown of academic impact, for papers by Bożena Chodynicka Breakdown of academic impact, for papers by Deepak Balak Breakdown of academic impact, for papers by S. George Breakdown of academic impact, for papers by Shuaihantian Luo
Rankless by CCL
2026